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Introduction
The current trend in using percutaneous devices in contemporary 
medicine and the increased dependence on advanced treatments with 
technologically improved delivery systems will produce a sustained 
growth in the number of patients undergoing procedures where a 
skin-implant interface will be present [1-3,12]. Increasingly, these 
bio interfaces will also become long-term or permanent interfaces. 
Typical complications originating from the use of these devices are 
break-down of the skin and serious infections which makes more 
difficult the formation of a long-term, stable dermal and epidermal 
sealing around the implants. These devices show high variability 
in their intrinsic properties, with a disparate number of material 
composition, surface structure, porosities and topologies [4,13]. 
Successfully addressing the problems originating at this bio interface 
will also be helpful to avoid or reduce complications in surgical 
procedures that require long-term permanent access to internal areas 
after total implantation [5,6,15].
To start addressing these issues with per cutaneous devices, we 
have previously presented two in vitro model systems to provide 
proof-of-concept of the feasibility of delivering materials at the 
skin-percutaneous device interface [7-9], permitting the analysis of 
the interface between skin and external devices. They were used to 
observe changes of the skin in contact with implants in the presence 
or absence of a variety of materials in solution, which were delivered 
manually and discontinuously or on a continuous basis using a fluid 
pump. We showed that the delivery process induced biological 
changes at the interface. Standard methods to address the problem 
typically involve coating the surfaces of the percutaneous devices 
with antimicrobial or other products. Those systems provide a non-
dynamic, non-repeatable method of delivering the products to the 
interface. Our hypothesis is that the delivery of specific biomaterials 
at this interface will create a dynamic, slowly flowing matrix for 
skin bio integration and the local administration of drugs or 
antimicrobials. Our essential concept is to incorporate a reservoir of 
material that can be slowly extruded at the implant-skin interface to 
protect the underlying tissue layers from the possibility of infection 
and inflammation or introduce regenerative materials or therapies, as 
discussed previously [10].
To further advance in solutions to help bioengineer the skin-
implant interface, here we present a simplified examination of the 
implementation of a technique using a novel double lumen catheter 
to deliver solutions in a controlled manner to the interface. In vitro 
human skin, a rabbit cadaver model and an in vivo rabbit model were 
used. The modifications were engineered to permit the dynamic 
delivery of liquids to the skin catheter area. Our expectation is that 
the modification of the catheter by the addition of a secondary, but 
shorter lumen will be helpful in controlling clinical conditions that may 
arise in the implant area over time, including control of inflammation 
or reduction of infections. In these preliminary experiments the 
catheters are inserted sub dermally, protruding from the skin and 
left in place for short periods of time while methylene blue solutions 
are pumped. In these preliminary experiments the objective is to 
determine the approximate areas affected by the pumping process 
and whether this system can be implemented in vivo.
Similar technologies are not available in current clinical practice. 
Some commercial catheters contain a single lumen while others have 
a double or triple lumen, but their purpose is to deliver solutions 
to the venous system, the peritoneum or other internal body areas, 
not to the areas of contact between the catheter and the skin or 
subcutaneous tissue. At this stage of the development, this system 
does not address luminal infections, which are normally addressed 
by coating the interior surfaces of the catheter with antimicrobials 
[16]. Some commercially available catheters have specially designed 
cuffs, containing antimicrobial compounds. The main drawback of 
both solutions is that they provide a non-dynamic, non–repeatable 
method of delivering the antimicrobials to the affected areas and 
that only one type of product, in this case, antimicrobials, can be 
delivered at the interface.
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Abstract
This paper shows the technical feasibility of using a modified double lumen catheter for the delivery of fluids at the 
skin-catheter interface in an in vivo rabbit model. The modified catheter permits the extrusion of suspensions at the 
site of contact between the skin and the modified catheter (exit site). The modification consisted in the addition of a 
second lumen, exterior to the original one of the catheter, and of shorter length, ending in an extrusion port placed sub 
dermally. An external fluid pump was attached to the catheter and the whole system was tested in vitro in human skin, 
in a cadaver model and in an in vivo rabbit model. Experiments were performed by delivering solutions of methylene 
blue in a controlled manner to the subcutaneous area to analyze the skin response to the process. Results indicate that 
this technique of pumping the material is effective in producing observable epithelial changes in the short term. The 
modification of the catheter addresses catheter exit site lack of integration of skin and works as a model that can be 
implemented in a number of percutaneous devices for long-term implantation.
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The ultimate goal is then the development of a system that 
will allow the physician to use an externally connected device for 
the delivery of solutions of his/her choice. This system will permit 
the treatment of conditions that the patient may develop over time 
around the interface without the need to open the area around 
the implant and reduce the risk of implant failure and retrieval. 
The results with the rabbit model presented here indicate that this 
modified device may be useful in humans for control, maintenance 
and repair of the skin-implant interface.
Materials and Methods
Experimental design
Figure 1 shows the modified double lumen catheter system. It 
consisted of an external pumping system composed of reservoir 
and pump, tubing and an external port and a subcutaneous delivery 
port. Two types of tubing were used. The outer tube (Silicon Rubber 
4mm OD, McMaster-Carr) connected the pump to the external port 
and continued to the delivery port. The internal tubing connected 
the external port to the delivery port. The liquid suspensions flew 
using the open space between the two tubes, which was a cylindrical 
section of 200 micrometer radius. The inner catheter was left empty. 
The delivery port was a cylinder made of commercial Teflon, radius 
1cm and length 2cm with three side openings for the release of 
liquids.
Preliminary experiments were performed with human skin in 
vitro obtained from discarded surgeries (Figure 2) followed by animal 
experiments in a cadaver model and in vivo (Figures 3 and 4). To adjust 
the system around the animals and prevent the rabbits from scratching 
catheters exit sites, rabbits wore a jacket (Lomir Biomedical, Quebec, 
Canada) with a pocket, where the device was placed. In the cadaver 
model a 1% methylene blue (MW 320) solution in distilled water was 
used, while in the human skin specimens and in vivo rabbit a 10% 
methylene blue solution was used. In the results presented, the pump 
used a pulsatile system connected to a timer (Crouzet USA, Texas) 
that discharged specified volumes of liquid during on periods and 
stopped during off periods of time. For the human skin experiments 
this produced an average flow of 0.6µl/min. For the rabbit cadaver 
model the average fluid rates were 0.1µl/min and 1µl/min and in 
Figure 1: Modification of a catheter with a secondary lumen and connection 
to an external pump and reservoir with the liquid. The system consists of a 
connecting port between the secondary lumen and the primary catheter. The 
liquid fluids only between the two catheters and is extruded at the extrusion port 
openings subdermally. The original catheter remains unmodified.
Figure 2: These images (A, B, D and D) show the process of delivering 10% 
methylene blue to human skin using the double catheter with the extrusion port 
for 20 hours at an average rate of 0.6 ul/min. The liquid flows in the lumen 
between the internal and external tubes and is released at the exit site. The 
original functionality of the internal catheter (i.e. peritoneal catheter or other) 
is maintained and not affected by this process. In the second row, histological 
analysis showed focal disruption in the epidermis accompanied by minimal focal 
epidermal necrosis as seen on image E. Visible on F is the overall area affected 
by the dye, reaching a depth of about 1mm and indicated by an arrow. Overall, 
the changes in this sample were minimal to mild and there was no significant 
epidermal or dermal damage.
Figure 3: The image below shows the procedure to insert the catheter on the 
dorsum of a rabbit (A, B and C) and distribution and testing time (D, E, F and 
G). To simplify the process, in this procedure the internal catheter is placed 
subdermally. To avoid additional injury to the exit site the catheter is placed 
without sutures. In second row, testing times and concentrations indicated 
that 1% methylene blue diffused into the epidermis, dermis and reached the 
panniculus muscle of the rabbit in the cadaver model. Over a 2 hour pumping 
period at 0.1 ul/min (D and E), the distribution of the dye formed a 1mm corona 
around the exit site. At 1 ul/min (F and G) the corona extended 2 mm with 
more methylene blue reaching the dermis. While the distribution around the 
epidermis always appears to be circular in shape, in the dermis the diffusion 
depends on the specific structural features of the tissue, and then the dye is 
present in irregular shapes. This distribution will obviously be different for other 
compounds.
Figure 4: A and B show normal epithelial structures of the rabbit. C,D,E show 
histology of sections of a skin of rabbit with a catheter implanted, but no pumped 
material (control). F, G and H show histology of skin of a rabbit where methylene 
blue 10% was delivered using the modified catheter for 2h at a rate of 1ul/min on 
the second day after implantation.
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the in vivo rabbit model the average pumping rate was 0.4µl/min. 
The tubing and pump were primed with the suspensions before the 
start of the experiment. Experiments performed in cadaver models 
of the animals provided basic information to determine the basic 
surgical procedures described and to obtain control skin sections and 
approximate distribution of the suspensions.
Animal surgery
The cadaver model and in vivo experiments were performed 
with New Zealand white rabbits weighing between 1.8 and 2.4 kg in 
accordance with the University of Michigan animal research facility 
guidelines. Animals were acclimated to the animal housing facility for 
at least 48 hours. Rabbits were fed a standard diet and were given 
water ad libitum. Rabbits fasted for 2 hours and were anesthetized 
by an intramuscular injection of dexdormitor (0.15 mg/kg) and 
maintained with isoflurane. Dorsum fur was removed with clippers 
and disinfected with chlorhexidine. A small incision was made to open 
the skin enough for the insertion of the modified catheter, as shown 
in Figure 3A. The procedure consisted in pulling the small diameter 
catheter sub dermally and securing the end to the skin approximately 
7cm from the exit site (to conform to current terminology used in 
the literature, we use the term “exit site” to describe the skin area 
where the delivery port is located). The terminal part of the internal 
catheter was secured with a knot without the need of suture. The 
delivery port was then placed sub dermally, as shown in Figure 3C, 
without suture. Two catheters were placed on the animals: one 
connected to the pumping system, the other used as control with no 
pump attached (catheter only). No antibiotics or products were given 
to the animal and the tissues around the area of the exit site were 
left to readjust mechanically to the delivery port for 24 hours before 
releasing any material in the in vivo model. A similar configuration 
was implemented in the cadaver rabbit model. In this later case, 
the catheter was placed immediately after death and pumping was 
performed for a maximum of two hours.
Analysis of soft tissue specimens
At the end of the pumping period specimens were analyzed for 
extension and distribution of the fluids. Basic pathology analysis 
was also done. For histological analysis, tissues were fixed in 10% 
phosphate buffered formalin for 24h, routinely dehydrated and 
paraffin embedded. Serial sections were obtained at 5µm. Histological 
evaluation of specimens was performed with haematoxylin and eosin 
(H&E).
Results
The configuration of the catheter system and the volumes 
perfused allowed the liquids to reach the fascia and muscle areas. 
No adhesive was used to bind the catheters to the subcutaneous 
tissues and no anti-microbials were used and the exit sites were free 
of bacterial infection. During the experiments, visual morphological 
changes of the tissues around the catheter were controlled. No 
gross morphological changes were observed during the experiments 
among the control and experimental specimens. The only noticeable 
change was the diffusion of methylene blue in all skin specimens. 
Animals were controlled to prevent scratching or substantial 
mechanical disturbances around the catheter exit site. This was done 
to prevent the occurrence of inflammatory processes not related to 
the presence of the catheter or the pumping process itself. Figure 
2 shows an example of human skin with the catheter delivering 
10% methylene blue for 20 hours at a rate of 0.6µl/min, for a total 
volume of 720µl. The liquid flows in the lumen between the internal 
and external tubes and is released at the exit site. The original 
functionality of the internal catheter (i.e. peritoneal catheter or 
other) is maintained and not affected by this process. The extrusion 
port was left semi-inserted to simulate the process where skin has to 
attach to external ports, as is common in peritoneal dialysis. In these 
static conditions the dye distributed radially from the port in the 
epidermis and diffused down to the dermis. There was a gradient of 
diffusion where the dye concentrated (intense blue) and dye was less 
intense far from the exit site (light blue). These areas extended up to 
1 cm from the entrance site in the configuration tested. Histological 
analysis of the human skin showed focal disruption in the epidermis 
accompanied by minimal focal epidermal necrosis as seen on Figure 
2E. Localized interstitial cell psychosis could also be observed. Visible 
on Figure 2F is the overall area affected by the dye, reaching a depth 
of about 1mm and indicated by an arrow. Overall, the changes in this 
sample were minimal to mild and there was no substantial epidermal 
or dermal damage.
As seen in Figure 3, testing times and concentrations indicated 
that 1% methylene blue diffused into the epidermis and dermis and 
reached the panniculus muscle of the rabbit in the cadaver model. 
Over a 2 hour pumping period at 0.1µl/min (Figure 3D and 3E, total 
volume 12µl), the distribution of the dye formed a 1mm corona 
around the exit site. At 1µl/min (Figure 3F and 3G total volume 120µl) 
the corona extended 2mm with more methylene blue reaching the 
dermis. While the distribution around the epidermis always appears 
to be circular in shape, in the dermis the diffusion depends on the 
specific structural features of the tissue, and then the dye is present 
in irregular shapes. It is expected this distribution will be different 
for other compounds.
Figure 4 is a composite figure with pictures of the histology of 
the specimens taken from the in vivo rabbit model. Figure 4A and 
Figure 4B show normal epithelial structures of the rabbit skin which 
has a very thin epidermis (1 or 2 cells). Figures 4C, 4D and 4E show 
sections of control catheter implanted but no pumped material 
(catheter control). Figures 4F, 4G and 4H show histology of sections 
where methylene blue 10% was delivered using the modified catheter 
at an average rate of 0.4lµ/min for 4 hours (total volume 96µl) on 
the second day of implantation. The surrounding areas where 
the catheters were implanted showed local areas of necrotizing 
dermatitis, more prominent on control specimen, while areas of skin 
away from the exit site showed skin histology within normal limits. 
In control catheter samples (C, D, E) there is locally extensive necrosis 
and heterophilic (neutrophilic) inflammation in the superficial dermis 
(arrow). The skin morphology adjacent to the area of necrosis and 
inflammation is within normal limits (arrow image E). In methylene 
blue catheter samples (F, G, H) there is also locally extensive necrosis 
and heterophilic inflammation in the affected area (double arrow, 
image F) but to a lesser degree than in the section above and adjacent 
areas of skin are normal. Black arrows indicate edge of inflammation. 
The histological alterations in both catheter samples are consistent 
with acute dermal irritation and necrosis.
Discussion
The system presented is a conceptual prototype, very simple in 
design, which was used experimentally to show that the delivery 
is possible. The implementation of this technique would be more 
difficult in small diameter catheters than in thick catheters. Real 
implementation essentially would require two things: miniaturization 
of the reservoir and pump and addition of the external lumen to a 
currently existing catheter. This is mostly an engineering work and 
design.
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In these preliminary experiments with animal cadavers we 
found that the volumes that can be perfuse daily subdermally need 
to be necessarily small, or otherwise they will remain sub dermally 
forming bursa fluids. In vivo, the distribution of the fluids was 
sometimes circularly shaped, centered on the catheter exit site and 
occasionally irregular and cone-shaped with orientation towards 
the continuing line of the catheter that can be observed both in the 
dermis and the epidermis. This issue is due in part to the reduced 
tissue thickness of the rabbit skin and the orientation of the delivery 
port. Implementation in humans, where the soft tissues are thicker, 
and using smaller delivery ports will result in more homogeneous 
distribution around the interface. In both cases, however, as seen in 
Figures 2 and 4, the liquids reached all areas of dermis and epidermis 
around the catheter, guaranteeing delivery around the interface.
The histological alterations in the catheter samples were consistent 
with acute short-term dermal irritation. This is likely a reversible 
change with removal of the irritant although the inflammatory 
reaction is always dependent on the place of implantation and the 
soft tissues present [11] and is species dependent [17]. The purpose 
of future experiments will be then to analyze the differences in tissue 
response delivering, for instance, anti inflammatory.
Conclusions
It is proposed that this technology, if implemented in humans, 
may help prevent or reduce infections and improve the epithelial 
integration with percutaneous devices. The configuration presented 
also includes the possibility of using refillable reservoirs for 
chronic delivery of compounds. In the case the skin interface this 
possibility would be particularly useful. The technology, with proper 
engineered modifications, could have widespread applicability. In 
the area of hemo dialysis and peritoneal dialysis there is great need 
for improvement in implantable device - tissue interface to promote 
healing, maintain function and prevent or treat infection.
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